Potassium Iodide Solution
NDC Package 75834-280-08
Package Information
Potassium Iodide solution is potassium iodide is used to loosen and break up mucus in the airways. This formulation utilizes a solution delivery system. Marketed by Nivagen Pharmaceuticals, Inc., this product is identified by NDC 75834-280.
Identification & Billing
- RxCUI: 312541 - potassium iodide 1 GM in 1 mL Oral Solution
- RxCUI: 312541 - potassium iodide 1000 MG/ML Oral Solution
- RxCUI: 312541 - K+ Iodide 1000 MG/ML Oral Solution
- RxCUI: 312541 - Pot Iodide 1000 MG/ML Oral Solution
- RxCUI: 312541 - potassium iodide 1 GM per 1 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 75834 - Nivagen Pharmaceuticals, Inc.
- 75834-280 - Potassium Iodide
- 75834-280-08 - 237 mL in 1 BOTTLE
- 75834-280 - Potassium Iodide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (75834-280). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 75834-280-08 identifies a specific commercial package of 237 ml in 1 bottle of Potassium Iodide, a human prescription drug labeled by Nivagen Pharmaceuticals, Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 237 billable units per package. This solution is formulated for oral use and contains potassium iodide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nivagen Pharmaceuticals, Inc. on December 29, 2021. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Potassium iodide is used to loosen and break up mucus in the airways. This helps you cough up the mucus so you can breathe more easily if you have long-term lung problems (e.g., asthma, chronic bronchitis, emphysema). This medication is known as an expectorant. Potassium iodide is also used along with antithyroid medicines to prepare the thyroid gland for surgical removal, to treat certain overactive thyroid conditions (hyperthyroidism), and to protect the thyroid in a radiation exposure emergency. It works by shrinking the size of the thyroid gland and decreasing the amount of thyroid hormones produced. In a radiation emergency, potassium iodide blocks only the thyroid from absorbing radioactive iodine, protecting it from damage and reducing the risk of thyroid cancer. Use this medication along with other emergency measures that will be recommended to you by public health and safety officials (e.g., finding safe shelter, evacuation, controlling food supply).
How is this Nivagen Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 75834028008. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 237 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.